In clear-cell renal-cell carcinoma (ccRCC), LILRB1+ TIL CD8 T cells exhibit reduced cytotoxicity in the presence of HLA-G-expressing target cells, which can be reversed by anti-HLA-G-mediated blockade [172]. The gene discussed is HLA-G; the disease is clear cell renal carcinoma.